Administration of Glutaredoxin-1 Attenuates Liver Fibrosis Caused by Aging and Non-Alcoholic Steatohepatitis is a research paper published in Antioxidants (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Whitaker Cardiovascular Institute
Grant: R01 HL133013
Whitaker Cardiovascular Institute
Grant: R03 AG 051857
Whitaker Cardiovascular Institute
Grant: R01 DK103750
Whitaker Cardiovascular Institute
Grant: 1UL1TR001430
NCATS NIH HHS
Grant: UL1 TR001430
NHLBI NIH HHS
Grant: T32 HL007224
National Institutes of Health
Grant: 5T32HL007224-20
BASIC SCIENCE CARDIOVASCULAR TRAINING PROGRAM
National Institutes of Health
Grant: 3UL1TR001430-05A1S2
Boston University Clinical and Translational Science Institute
National Institutes of Health
Grant: 3R03AG051857-02S1
Regulation of ischemic vascularization by glutaredoxin-1 by aging
National Institutes of Health
Grant: 5R01HL133013-04
Regulation of ischemic limb vascularization by glutaredoxin-1
National Institutes of Health
Grant: 5R01DK103750-04
Redox control of hepatic lipid metabolism
FWCI
1.91
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals